XLVIvsIHIETF Comparison
ETF 1
XLVI
State Street Health Care Select Sector SPDR Premium Income Fund
This fund is part of
Options Strategies
+0.51%
VS
State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) belongs to the Options Strategies segment. iShares U.S. Medical Devices ETF (IHI) is part of the US Health Care segment. XLVI's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, IHI's top sector exposures are Healthcare, Non-Corporate and Finance. XLVI is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.37% for IHI. XLVI is up 5.51% year-to-date (YTD) with +$15M in YTD flows. IHI performs worse with -17.93% YTD performance, and -$160M in YTD flows. Run a side-by-side ETF comparison of XLVI and IHI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLVI vs IHI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/11/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLVI IHI | -3.84%-9.10% | +3.50%+2.59% | +5.51%-17.93% | +15.67%-17.27% | n/a+0.72% | n/a-20.04% |
| Flows | XLVI IHI | +$5M+$37M | +$12M+$31M | +$15M-$160M | +$25M-$428M | --$2.54B | --$3.80B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLVI IHI | +11.87%+26.28% | +11.08%+20.34% | n/a+18.40% | n/a+19.80% |
| Max drawdown | XLVI IHI | -4.94%-10.11% | -8.21%-26.18% | n/a-26.72% | n/a-32.36% |
| Max drawdown duration | XLVI IHI | 17d23d | 115d290d | n/a583d | n/a1719d |
Trading data
XLVI | IHI | |
Last sale 9/11/2026 at 1:30 PM | $25.71 | $50.88 |
| Previous close 09/10/2026 | $25.73 | $50.90 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XLVI
is actively managed and doesn’t replicate an indexXLVI | IHI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
XLVI | IHI | |
|---|---|---|
| Last price | $25.71 | $50.88 |
| 1D performance | -0.07% | -0.04% |
| AuM | $26.19 M | $3.18 B |
| E/R | 0.35% | 0.37% |
Characteristics
XLVI | IHI | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | State Street Investment Management | iShares |
| Benchmark | - | Dow Jones U.S. Select Medical Equipment Index |
| N° of holdings | 59 | 47 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | July 30, 2025 | May 1, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
XLVI
USA
97.34%
Other
2.66%
IHI
USA
91.29%
Ireland
7.82%
Other
0.88%
Sectors
XLVI
Healthcare
97.32%
Other
2.68%
IHI
Healthcare
99.85%
Other
0.15%
Advertisement
Diversification
XLVI
Total weight of top 15 holdings out of 15
71.63%
IHI
Total weight of top 15 holdings out of 15
87.99%
Top 15 holdings
Data as of July 31, 2026
XLVI
Eli Lilly & Co.
15.45%
Johnson & Johnson
10.49%
AbbVie, Inc.
7.54%
UnitedHealth Group, Inc.
6.40%
Merck & Co., Inc.
5.47%
Thermo Fisher Scientific, Inc.
3.63%
Amgen, Inc.
3.53%
Abbott Laboratories
3.13%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.42%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
IHI
Abbott Laboratories
18.49%
Intuitive Surgical, Inc.
12.57%
Stryker Corp.
12.07%
Becton, Dickinson & Co.
4.75%
GE Healthcare Technologies, Inc.
4.62%
Medtronic Plc
4.53%
ResMed, Inc.
4.40%
Edwards Lifesciences Corp.
4.29%
IDEXX Laboratories, Inc.
4.25%
DexCom, Inc.
4.18%
Boston Scientific Corp.
4.03%
STERIS Plc (Ireland)
3.30%
Zimmer Biomet Holdings, Inc.
2.67%
Baxter International, Inc.
2.01%
Penumbra, Inc.
1.83%
Frequently asked questions about XLVI and IHI
How have the XLVI and IHI ETFs performed in 2026?
As of September 11, 2026, XLVI is up 5.51% year-to-date (YTD), while IHI has lost -17.93%. That puts XLVI better performer ahead so far this year.
Which ETF is attracting more investor money: XLVI or IHI?
Year-to-date, the XLVI ETF saw +$15M in flows, compared to -$160M for IHI.
Which ETF is more volatile: XLVI or IHI?
Over the past year, XLVI had a volatility of 11.08%, while IHI experienced 20.34%.
Which ETF is bigger: XLVI or IHI?
As of September 11, 2026, XLVI holds $26.19 M in assets under management (AUM), while IHI manages $3.18 B.
What sectors do the XLVI and IHI ETFs invest in?
XLVI leans toward sectors like Healthcare. Meanwhile, IHI focuses on Healthcare.
What are the top holdings of the XLVI ETF and IHI ETF?
XLVI top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. IHI holds in its top three: Abbott Laboratories, Intuitive Surgical, Inc. and Stryker Corp..
Which ETF is more diversified: XLVI or IHI?
XLVI holds 59 securities with 71.63% of its assets in the top 15. IHI has 47 securities and a top 15 weight of 87.99%.
Advertisement
Latest news about XLVI & IHI
Notable ETF Filings Recap: April 2024
May 2, 2024
IHI
Health Care Sector Down After a Cyberattack on UnitedHealth
March 4, 2024
IHI
Investing in the Aging Demographics Megatrend
February 28, 2023
IHI
Advertisement
Advertisement
